Analyst Consensus ?
ConsensusHold41 ratings
Bullish2253.7%
Neutral1639.0%
Bearish37.3%
FN2 Earnings Intelligence
Amgen Inc. complete analyst coverage
Amgen Inc. (AMGN) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$444.63Current
$182Low
$353.2Average
$500High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 26, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Oppenheimer | Outperform | Outperform | Maintain | Oct 23, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Oct 21, 2026 |
| Guggenheim | Neutral | Neutral | Maintain | Oct 13, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Oct 12, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Oct 12, 2026 |
| UBS | Buy | Buy | Maintain | Oct 9, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Oct 8, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Oct 8, 2026 |
| Truist Securities | Hold | Hold | Maintain | Oct 7, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Oct 7, 2026 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Sep 29, 2026 |
| HSBC | Hold | Buy | Downgrade | Sep 10, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Aug 20, 2026 |
| Argus Research | Buy | Buy | Maintain | Aug 19, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Aug 18, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Aug 7, 2026 |
| Bernstein | Market Perform | Market Perform | Maintain | Aug 6, 2026 |
| TD Cowen | Buy | Buy | Maintain | Aug 5, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Aug 5, 2026 |
| Canaccord Genuity | Hold | Hold | Maintain | Aug 5, 2026 |
| Baird | Underperform | Underperform | Maintain | Aug 5, 2026 |
| B of A Securities | Underperform | Underperform | Maintain | Aug 5, 2026 |
| Freedom Broker | Hold | Buy | Downgrade | Feb 12, 2026 |
| Leerink Partners | Outperform | Outperform | Maintain | Feb 4, 2026 |
| Jefferies | Buy | Buy | Maintain | Nov 12, 2024 |
| Deutsche Bank | Hold | Hold | Maintain | Aug 7, 2024 |
| William Blair | Outperform | Market Perform | Upgrade | May 3, 2024 |
| Daiwa Capital | Buy | Neutral | Upgrade | Dec 21, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Jul 12, 2023 |
| SVB Leerink | Market Perform | Market Perform | Maintain | Feb 2, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 1, 2023 |
| Atlantic Equities | Underweight | Underweight | Maintain | Aug 9, 2022 |
| Raymond James | Outperform | Market Perform | Upgrade | Oct 26, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Jul 30, 2020 |
| JP Morgan | Neutral | Neutral | Maintain | Jul 29, 2020 |
| CFRA | Buy | Buy | Maintain | May 1, 2020 |
| Evercore ISI Group | Outperform | In Line | Upgrade | Jan 21, 2020 |
| PiperJaffray | Overweight | Overweight | Maintain | Jul 27, 2018 |
| Argus | Buy | Hold | Upgrade | May 5, 2018 |
| Bank of America | Buy | Neutral | Upgrade | Feb 1, 2017 |
| Nomura | Buy | Buy | Maintain | Sep 22, 2015 |
Named analyst price targets
Upside is calculated against the persisted current price $444.63. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Oppenheimer | Analyst unavailable | $480 | $447.28 | +8.0% | Oct 23, 2026 |
| Barclays | Analyst unavailable | $400 | $438.94 | -10.0% | Oct 21, 2026 |
| Guggenheim | Vamil Divan | $378 | $417.57 | -15.0% | Oct 13, 2026 |
| BMO Capital | Analyst unavailable | $415 | $415.8 | -6.7% | Oct 12, 2026 |
| Wells Fargo | Analyst unavailable | $430 | $414.87 | -3.3% | Oct 12, 2026 |
| RBC Capital | Analyst unavailable | $430 | $407.58 | -3.3% | Oct 8, 2026 |
| Cantor Fitzgerald | Carter Gould | $440 | $413.08 | -1.0% | Oct 8, 2026 |
| Truist Financial | Analyst unavailable | $380 | $413.67 | -14.5% | Oct 7, 2026 |
| Scotiabank | Louise Chen | $500 | $417.71 | +12.5% | Sep 28, 2026 |
| Jefferies | Akash Tewari | $410 | $410.24 | -7.8% | Sep 23, 2026 |
| UBS | Michael Yee | $430 | $378.42 | -3.3% | Sep 17, 2026 |
| Wells Fargo | Mohit Bansal | $435 | $444.12 | -2.2% | Sep 4, 2026 |
| Piper Sandler | David Amsellem | $457 | $442.36 | +2.8% | Aug 20, 2026 |
| Morgan Stanley | Analyst unavailable | $362 | $440.28 | -18.6% | Aug 19, 2026 |
| Argus Research | Analyst unavailable | $460 | $439.95 | +3.5% | Aug 19, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $400 | $419.38 | -10.0% | Aug 18, 2026 |
| Mizuho Securities | Analyst unavailable | $352 | $419.38 | -20.8% | Aug 18, 2026 |
| Barclays | Emily Field | $380 | $417.84 | -14.5% | Aug 14, 2026 |
| Guggenheim | Vamil Divan | $388 | $410.94 | -12.7% | Aug 10, 2026 |
| Bernstein | Analyst unavailable | $345 | $407.83 | -22.4% | Aug 6, 2026 |
| Scotiabank | Louise Chen | $450 | $406.25 | +1.2% | Aug 5, 2026 |
| Oppenheimer | Analyst unavailable | $450 | $390.02 | +1.2% | Aug 5, 2026 |
| RBC Capital | Analyst unavailable | $400 | $390.02 | -10.0% | Aug 5, 2026 |
| Robert W. Baird | Brian Skorney | $230 | $390.02 | -48.3% | Aug 5, 2026 |
| Canaccord Genuity | Gary Nachman | $384 | $390.02 | -13.6% | Aug 5, 2026 |
| BMO Capital | Evan Seigerman | $450 | $390.02 | +1.2% | Aug 5, 2026 |
| Barclays | Emily Field | $360 | $393.1 | -19.0% | Jul 29, 2026 |
| UBS | Analyst unavailable | $420 | $358.68 | -5.5% | Jul 13, 2026 |
| Guggenheim | Analyst unavailable | $343 | $363.39 | -22.9% | Jul 13, 2026 |
| Morgan Stanley | Analyst unavailable | $333 | $368.1 | -25.1% | Jul 8, 2026 |
| BMO Capital | Evan David Seigerman | $400 | $362.45 | -10.0% | Jul 1, 2026 |
| Mizuho Securities | Salim Syed | $303 | $350.53 | -31.9% | Jun 16, 2026 |
| Morgan Stanley | Analyst unavailable | $340 | $344.56 | -23.5% | Jun 9, 2026 |
| Goldman Sachs | Analyst unavailable | $389 | $352.62 | -12.5% | Jun 5, 2026 |
| Piper Sandler | Analyst unavailable | $427 | $336.45 | -4.0% | May 14, 2026 |
| Guggenheim | Analyst unavailable | $340 | $329.82 | -23.5% | May 4, 2026 |
| Morgan Stanley | Analyst unavailable | $332 | $329.3 | -25.3% | May 1, 2026 |
| Canaccord Genuity | Analyst unavailable | $366 | $350.16 | -17.7% | Apr 20, 2026 |
| Morgan Stanley | Terence Flynn | $326 | $352.59 | -26.7% | Apr 10, 2026 |
| Guggenheim | Analyst unavailable | $351 | $355.6 | -21.1% | Apr 9, 2026 |
| Truist Financial | Analyst unavailable | $325 | $349.81 | -26.9% | Apr 8, 2026 |
| Jefferies | Akash Tewari | $350 | $373.08 | -21.3% | Mar 10, 2026 |
| Leerink Partners | David Risinger | $355 | $367.6 | -20.2% | Mar 5, 2026 |
| Barclays | Analyst unavailable | $185 | $375.5 | -58.4% | Feb 19, 2026 |
| Wells Fargo | Analyst unavailable | $375 | $379.73 | -15.7% | Feb 19, 2026 |
| Piper Sandler | Analyst unavailable | $432 | $373.36 | -2.8% | Feb 18, 2026 |
| Mizuho Securities | Analyst unavailable | $295 | $364.65 | -33.7% | Feb 11, 2026 |
| RBC Capital | Analyst unavailable | $360 | $357.29 | -19.0% | Feb 4, 2026 |
| Morgan Stanley | Analyst unavailable | $309 | $351.81 | -30.5% | Feb 4, 2026 |
| Oppenheimer | Analyst unavailable | $400 | $343.57 | -10.0% | Jan 29, 2026 |
| UBS | Analyst unavailable | $390 | $348.99 | -12.3% | Jan 26, 2026 |
| Bernstein | Market Perform | $335 | $330.44 | -24.7% | Jan 20, 2026 |
| UBS | Analyst unavailable | $380 | $330.17 | -14.5% | Jan 6, 2026 |
| Morgan Stanley | Analyst unavailable | $304 | $317.67 | -31.6% | Dec 12, 2025 |
| HSBC | Analyst unavailable | $425 | $313.85 | -4.4% | Dec 10, 2025 |
| BMO Capital | Evan Seigerman | $372 | $338.36 | -16.3% | Dec 3, 2025 |
| Wells Fargo | Analyst unavailable | $400 | $334.3 | -10.0% | Nov 25, 2025 |
| Truist Financial | Analyst unavailable | $318 | $336.2 | -28.5% | Nov 24, 2025 |
| Piper Sandler | David Amsellem | $381 | $332.43 | -14.3% | Nov 14, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $315 | $318.4 | -29.2% | Nov 6, 2025 |
| Wells Fargo | Analyst unavailable | $300 | $296.7 | -32.5% | Nov 5, 2025 |
| Piper Sandler | Analyst unavailable | $342 | $288.47 | -23.1% | Aug 25, 2025 |
| UBS | Trung Huynh | $315 | $281.22 | -29.2% | May 2, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $305 | $278.4 | -31.4% | Apr 22, 2025 |
| Johnson Rice | Analyst unavailable | $294 | $316.57 | -33.9% | Mar 5, 2025 |
| Jefferies | Michael Yee | $380 | $298.84 | -14.5% | Nov 12, 2024 |
| Cantor Fitzgerald | Olivia Brayer | $405 | $298.84 | -8.9% | Nov 12, 2024 |
| Morgan Stanley | Terence Flynn | $319 | $316.74 | -28.3% | Oct 21, 2024 |
| Goldman Sachs | Salveen Richter | $369 | $325.09 | -17.0% | Oct 16, 2024 |
| Barclays | Carter Gould | $315 | $319.66 | -29.2% | Oct 7, 2024 |
| BMO Capital | Evan David Seigerman | $362 | $330.92 | -18.6% | Sep 25, 2024 |
| Raymond James | Christopher Raymond | $344 | $330.92 | -22.6% | Sep 25, 2024 |
| Robert W. Baird | Brian Skorney | $215 | $330.92 | -51.6% | Sep 25, 2024 |
| Wells Fargo | Mohit Bansal | $335 | $328.95 | -24.7% | Aug 7, 2024 |
| Morgan Stanley | Terence Flynn | $303 | $330.78 | -31.9% | Aug 6, 2024 |
| RBC Capital | Gregory Renza | $332 | $298.71 | -25.3% | Jun 14, 2024 |
| Oppenheimer | Jay Olson | $380 | $312.32 | -14.5% | May 17, 2024 |
| Mizuho Securities | Salim Syed | $235 | $307.31 | -47.1% | May 9, 2024 |
| Morgan Stanley | Terence Flynn | $310 | $315.19 | -30.3% | May 3, 2024 |
| BMO Capital | Evan David Seigerman | $355 | $278.39 | -20.2% | May 3, 2024 |
| UBS | Colin Bristow | $307 | $278.39 | -31.0% | May 3, 2024 |
| Barclays | Carter Gould | $300 | $278.39 | -32.5% | May 3, 2024 |
| Wells Fargo | Mohit Bansal | $320 | $265.1 | -28.0% | Apr 17, 2024 |
| Oppenheimer | Jay Olson | $280 | $260.31 | -37.0% | Sep 13, 2023 |
| Wells Fargo | Mohit Bansal | $265 | $251.08 | -40.4% | Apr 12, 2023 |
| Wells Fargo | Mohit Bansal | $275 | $228.84 | -38.2% | Mar 10, 2023 |
| Leerink Partners | Analyst unavailable | $267 | $246.41 | -40.0% | Feb 2, 2023 |
| RBC Capital | Analyst unavailable | $258 | $242.92 | -42.0% | Feb 1, 2023 |
| Oppenheimer | Analyst unavailable | $294 | $243.8 | -33.9% | Feb 1, 2023 |
| Cowen & Co. | Analyst unavailable | $289 | $243.47 | -35.0% | Feb 1, 2023 |
| BMO Capital | Analyst unavailable | $253 | $252.4 | -43.1% | Feb 1, 2023 |
| Wells Fargo | Analyst unavailable | $285 | $260.67 | -35.9% | Jan 3, 2023 |
| Leerink Partners | Analyst unavailable | $282 | $266.26 | -36.6% | Dec 22, 2022 |
| Piper Sandler | Analyst unavailable | $299 | $276.78 | -32.8% | Dec 13, 2022 |
| Oppenheimer | Analyst unavailable | $310 | $285.59 | -30.3% | Dec 6, 2022 |
| Raymond James | Christopher Raymond | $297 | $285.72 | -33.2% | Dec 5, 2022 |
| Credit Suisse | Analyst unavailable | $240 | $287.3 | -46.0% | Nov 18, 2022 |
| Barclays | Carter Gould | $234 | $273.81 | -47.4% | Oct 31, 2022 |
| Atlantic Equities | Analyst unavailable | $182 | $247.29 | -59.1% | Aug 9, 2022 |
| RBC Capital | Analyst unavailable | $236 | $246.98 | -46.9% | Aug 5, 2022 |
| Piper Sandler | Analyst unavailable | $265 | $246.98 | -40.4% | Aug 5, 2022 |
| Morgan Stanley | Analyst unavailable | $253 | $247.87 | -43.1% | Jul 15, 2022 |
| Oppenheimer | Jay Olson | $290 | $248.94 | -34.8% | Jun 3, 2022 |
| Mizuho Securities | Salim Syed | $208 | $239.24 | -53.2% | May 10, 2022 |
| BMO Capital | Evan Seigerman | $243 | $238.13 | -45.3% | Apr 29, 2022 |
| Barclays | Carter Gould | $236 | $254.02 | -46.9% | Apr 16, 2022 |
| BMO Capital | Evan David Seigerman | $240 | $220.77 | -46.0% | Feb 21, 2022 |
| UBS | Colin Bristow | $232 | $238.96 | -47.8% | Feb 8, 2022 |
| Piper Sandler | Christopher Raymond | $255 | $238.96 | -42.6% | Feb 8, 2022 |
| RBC Capital | Kennen MacKay | $218 | $238.96 | -51.0% | Feb 8, 2022 |
| Cowen & Co. | Yaron Werber | $275 | $222.1 | -38.2% | Jan 27, 2022 |
| Bank of America Securities | Geoff Meacham | $255 | $223.23 | -42.6% | Jan 5, 2022 |
| Goldman Sachs | Salveen Richter | $258 | $207.02 | -42.0% | Dec 6, 2021 |
| Wolfe Research | Tim Anderson | $230 | $214.47 | -48.3% | Nov 3, 2021 |
| DZ BANK AG | Elmar Kraus | $278 | $228.31 | -37.5% | Aug 5, 2021 |
| Atlantic Equities | Steve Chesney | $200 | $229.35 | -55.0% | Apr 28, 2021 |
| Credit Suisse | Tiago Fauth | $259 | $229.35 | -41.7% | Apr 28, 2021 |
Track every rating change on AMGN the moment it posts. Free to start.
Start freeGet the AMGN recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.